Loading...

Visioneering Technologies

ASX:VTI
Snowflake Description

Adequate balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
VTI
ASX
A$18M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of its NaturalVue daily disposable multi-focal contact lenses for adults with presbyopia and children with myopia in the United States. The last earnings update was 64 days ago. More info.


Add to Portfolio Compare Print
  • Visioneering Technologies has significant price volatility in the past 3 months.
VTI Share Price and Events
7 Day Returns
13.3%
ASX:VTI
3.2%
AU Medical Equipment
-0%
AU Market
1 Year Returns
-81.1%
ASX:VTI
-2.2%
AU Medical Equipment
4.6%
AU Market
VTI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Visioneering Technologies (VTI) 13.3% 6.3% -50% -81.1% - -
AU Medical Equipment 3.2% -0.5% 0.8% -2.2% 38.7% 105%
AU Market -0% 1% 6.9% 4.6% 18.2% 4.8%
1 Year Return vs Industry and Market
  • VTI underperformed the Medical Equipment industry which returned -2.2% over the past year.
  • VTI underperformed the Market in Australia which returned 4.6% over the past year.
Price Volatility
VTI
Industry
5yr Volatility vs Market

VTI Value

 Is Visioneering Technologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Visioneering Technologies. This is due to cash flow or dividend data being unavailable. The share price is A$0.085.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Visioneering Technologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Visioneering Technologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:VTI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.08
ASX:VTI Share Price ** ASX (2019-04-23) in AUD A$0.09
ASX:VTI Share Price converted to USD reporting currency Exchange rate (AUD/ USD) 0.713 $0.06
Australia Medical Equipment Industry PE Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 33.38x
Australia Market PE Ratio Median Figure of 544 Publicly-Listed Companies 16.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Visioneering Technologies.

ASX:VTI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:VTI Share Price ÷ EPS (both in USD)

= 0.06 ÷ -0.08

-0.78x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Visioneering Technologies is loss making, we can't compare its value to the AU Medical Equipment industry average.
  • Visioneering Technologies is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does Visioneering Technologies's expected growth come at a high price?
Raw Data
ASX:VTI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.78x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
Oceania Medical Equipment Industry PEG Ratio Median Figure of 5 Publicly-Listed Medical Equipment Companies 2.62x
Australia Market PEG Ratio Median Figure of 360 Publicly-Listed Companies 1.35x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Visioneering Technologies, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Visioneering Technologies's assets?
Raw Data
ASX:VTI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.04
ASX:VTI Share Price * ASX (2019-04-23) in AUD A$0.09
ASX:VTI Share Price converted to USD reporting currency Exchange rate (AUD/ USD) 0.713 $0.06
Australia Medical Equipment Industry PB Ratio Median Figure of 30 Publicly-Listed Medical Equipment Companies 2.72x
Australia Market PB Ratio Median Figure of 1,676 Publicly-Listed Companies 1.67x
ASX:VTI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:VTI Share Price ÷ Book Value per Share (both in USD)

= 0.06 ÷ 0.04

1.68x

* Primary Listing of Visioneering Technologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Visioneering Technologies is good value based on assets compared to the AU Medical Equipment industry average.
X
Value checks
We assess Visioneering Technologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Visioneering Technologies has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

VTI Future Performance

 How is Visioneering Technologies expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
48.5%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Visioneering Technologies expected to grow at an attractive rate?
  • Unable to compare Visioneering Technologies's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Visioneering Technologies's earnings growth to the Australia market average as no estimate data is available.
  • Visioneering Technologies's revenue growth is expected to exceed the Australia market average.
Annual Growth Rates Comparison
Raw Data
ASX:VTI Future Growth Rates Data Sources
Data Point Source Value (per year)
ASX:VTI Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 48.5%
Australia Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 13.2%
Australia Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.4%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.7%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:VTI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:VTI Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 38 1
2021-12-31 28 1
2020-12-31 16 1
2019-12-31 8 1
ASX:VTI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 3 -16 -17
2018-09-30 3 -16 -17
2018-06-30 2 -16 -17
2018-03-31 1 -14 -17
2017-12-31 1 -12 -17
2017-09-30 1 -11 -17
2017-06-30 0 -10 -17
2017-03-31 0 -8 -13
2016-12-31 0 -6 -8

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Visioneering Technologies is high growth as no earnings estimate data is available.
  • Visioneering Technologies's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:VTI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Visioneering Technologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:VTI Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31
2019-12-31
ASX:VTI Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.08
2018-09-30 -0.08
2018-06-30 -0.09
2018-03-31 -0.10
2017-12-31 -0.11
2017-09-30 -0.16
2017-06-30 -0.28
2017-03-31 -0.36
2016-12-31 -1.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Visioneering Technologies will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Visioneering Technologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Visioneering Technologies has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

VTI Past Performance

  How has Visioneering Technologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Visioneering Technologies's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Visioneering Technologies does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Visioneering Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Visioneering Technologies's 1-year growth to the AU Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Visioneering Technologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Visioneering Technologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:VTI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 3.29 -16.74 14.22
2018-09-30 2.60 -16.86 14.30
2018-06-30 1.91 -16.98 14.38
2018-03-31 1.48 -16.98 12.88
2017-12-31 1.05 -16.98 11.38
2017-09-30 0.75 -17.00 9.31
2017-06-30 0.45 -17.03 7.25
2017-03-31 0.33 -12.67 5.15
2016-12-31 0.22 -8.31 3.05
2015-12-31 0.05 -3.03 2.45
2014-12-31 -1.98 1.68

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Visioneering Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Visioneering Technologies has efficiently used its assets last year compared to the AU Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Visioneering Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Visioneering Technologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Visioneering Technologies has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

VTI Health

 How is Visioneering Technologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Visioneering Technologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Visioneering Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Visioneering Technologies's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Visioneering Technologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Visioneering Technologies has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Visioneering Technologies Company Filings, last reported 3 months ago.

ASX:VTI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 8.97 0.00 7.28
2018-09-30 8.97 0.00 7.28
2018-06-30 9.33 0.00 7.10
2018-03-31 9.33 0.00 7.10
2017-12-31 19.19 0.00 16.58
2017-09-30 19.19 0.00 16.58
2017-06-30 25.77 0.00 23.40
2017-03-31 25.77 0.00 23.40
2016-12-31 -17.29 18.01 5.67
2015-12-31
2014-12-31
  • Visioneering Technologies has no debt.
  • Visioneering Technologies currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Visioneering Technologies has less than a year of cash runway based on current free cash flow.
  • Visioneering Technologies has less than a year of cash runway if free cash flow continues to grow at historical rates of 43.7% each year.
X
Financial health checks
We assess Visioneering Technologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Visioneering Technologies has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

VTI Dividends

 What is Visioneering Technologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Visioneering Technologies dividends.
If you bought A$2,000 of Visioneering Technologies shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Visioneering Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Visioneering Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:VTI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Oceania Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.7%
Australia Market Average Dividend Yield Market Cap Weighted Average of 417 Stocks 4.3%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.5%
Australia Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:VTI Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Visioneering Technologies has not reported any payouts.
  • Unable to verify if Visioneering Technologies's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Visioneering Technologies's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Visioneering Technologies has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Visioneering Technologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Visioneering Technologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Visioneering Technologies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

VTI Management

 What is the CEO of Visioneering Technologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Stephen Snowdy
AGE 48
TENURE AS CEO 5.8 years
CEO Bio

Dr. Stephen Snowdy, Ph,D., has been Chief Executive Officer of Visioneering Technologies, Inc. June 2013 and serves as its President and Executive Director. Dr. Snowdy is a Principal at Memphis Biomed Ventures I, L.P. He is a Partner of MB Venture Partners. He joined MB Venture Partners in 2003. He spent the following two years as a Research Scientist at University of Florida. He serves as the Chairman of Calosy Pharma and Visioneering Technologies. He serves on the Board of Southwest Bio. He served on the Board of NVSS Corp. (formerly, Alveolus, Inc.). He serves as an Official Observer on the Boards at KFx Medical Corporation and KFx, Inc. He served as Director of Protein Discovery Inc. He served as Director of Kereos, Inc. since 2005. He was serviced at the United States Navy as a Member of an elite Special Forces unit in submarine warfare and as a Navy diver. His Ph.D., undergraduate and post-bacclaureate studies culminated in several publications. Dr. Snowdy is the first person to simultaneously complete a Ph.D. and an M.B.A. degree at the University of North Carolina (UNC) in Chapel Hill. He earned a Ph.D. in Neurobiology where he completed his dissertation on “Mechanisms of nuclear targeting by adeno-associated virus virons and capsid proteins” focused on studying the mechanisms by which viruses make their way through the cells that they infect, an M.B.A. with a concentration in Finance and a Bachelor's degree in Chemistry from the University of Florida.

CEO Compensation
  • Insufficient data for Stephen to compare compensation growth.
  • Insufficient data for Stephen to establish whether their remuneration is reasonable compared to companies of similar size in Australia.
Management Team Tenure

Average tenure of the Visioneering Technologies management team in years:

2
Average Tenure
  • The average tenure for the Visioneering Technologies management team is less than 2 years, this suggests a new team.
Management Team

Stephen Snowdy

TITLE
CEO, President & Executive Director
AGE
48
TENURE
5.8 yrs

Richard Griffin

TITLE
Founder & Medical Adviser

Brian Lane

TITLE
Chief Financial Officer
AGE
56
TENURE
0.3 yrs

Tony Sommer

TITLE
Senior Vice President of Sales & Marketing
TENURE
2.6 yrs

Sally Dillehay

TITLE
Chief Medical Officer

Julian Rockett

TITLE
Company Secretary
TENURE
0.2 yrs

Layna Mendlinger

TITLE
Executive Director of Marketing

Rosa Lee

TITLE
Executive Director of Manufacturing & Engineering
TENURE
2.3 yrs

Doug Benoit

TITLE
Executive Director of Professional Affairs
TENURE
1.6 yrs
Board of Directors Tenure

Average tenure and age of the Visioneering Technologies board of directors in years:

1.9
Average Tenure
53
Average Age
  • The average tenure for the Visioneering Technologies board of directors is less than 3 years, this suggests a new board.
Board of Directors

Fred Schwarzer

TITLE
Chairman of the Board
AGE
65

Stephen Snowdy

TITLE
CEO, President & Executive Director
AGE
48

Rosa Lee

TITLE
Executive Director of Manufacturing & Engineering
TENURE
2.3 yrs

Zita Peach

TITLE
Non-Executive Director
AGE
53

Jean Franchi

TITLE
Non-Executive Director
AGE
52
TENURE
1.3 yrs

Christi van Heek

TITLE
Non-Executive Director
AGE
61

Tom Dooley

TITLE
Non-Executive Director
TENURE
1.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
16. Apr 19 Sell Renaissance Smaller Companies Pty Ltd Company 10. Apr 19 12. Apr 19 -524,548 A$0.08 A$-40,851
11. Apr 19 Sell Renaissance Smaller Companies Pty Ltd Company 29. Mar 17 09. Apr 19 -1,394,495 A$0.10 A$-136,603
11. Apr 19 Buy Renaissance Smaller Companies Pty Ltd Company 29. Mar 17 09. Apr 19 1,666,667 A$0.18 A$299,999
04. Apr 19 Sell Kinetic Investment Partners Limited Company 05. Mar 19 02. Apr 19 -808,755 A$0.07 A$-53,676
06. Mar 19 Sell Kinetic Investment Partners Limited Company 21. Aug 18 04. Mar 19 -354,743 A$0.17 A$-61,477
06. Mar 19 Buy Kinetic Investment Partners Limited Company 21. Aug 18 04. Mar 19 354,743 A$0.17 A$61,477
26. Feb 19 Sell Regal Funds Management Pty Limited Company 29. Aug 18 22. Feb 19 -3,313,767 A$0.15 A$-496,641
16. Sep 18 Buy Zita Peach Individual 12. Sep 18 12. Sep 18 83,333 A$0.18 A$15,000
22. Aug 18 Sell Kinetic Investment Partners Limited Company 20. Apr 18 20. Aug 18 -100,000 A$0.36 A$-36,080
22. Aug 18 Buy Kinetic Investment Partners Limited Company 20. Apr 18 20. Aug 18 7,044,445 A$0.18 A$1,286,055
21. Aug 18 Sell Regal Funds Management Pty Limited Company 07. Dec 17 26. Jul 18 -2,671,017 A$0.37 A$-975,727
21. Aug 18 Buy Regal Funds Management Pty Limited Company 30. Jan 18 21. Aug 18 12,216,993 A$0.20 A$2,486,584
X
Management checks
We assess Visioneering Technologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Visioneering Technologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

VTI News

Simply Wall St News

What does Visioneering Technologies, Inc.'s (ASX:VTI) Balance Sheet Tell Us About Its Future?

However, it also faces higher cost of capital given interest cost is generally lower than equity. … Does VTI's growth rate justify its decision for financial flexibility over lower cost of capital … There are well-known benefits of including debt in capital structure, primarily a lower cost of capital.

Simply Wall St -

Do Institutions Own Visioneering Technologies Inc (ASX:VTI) Shares?

Generally speaking, as a company grows, institutions will increase their ownership. … Visioneering Technologies is not a large company by global standards. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St -

What Does Visioneering Technologies Inc's (ASX:VTI) Ownership Structure Look Like?

In this analysis, my focus will be on developing a perspective on Visioneering Technologies Inc’s (ASX:VTI) latest ownership structure, a less discussed, but important factor. … Ownership structure of a company has been found to affect share performance over time. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment.

Simply Wall St -

Visioneering Technologies Inc's (ASX:VTI) Single Biggest Risk For Investors

Looking at Visioneering Technologies’s latest financial data, I will gauge when the company may run out of cash and need to raise more money. … The measure of how fast Visioneering Technologies goes through its cash reserves over time is called the cash burn rate. … ASX:VTI Income Statement May 15th 18 When will Visioneering Technologies need to raise more cash?

Simply Wall St -

Who Really Owns Visioneering Technologies Inc (ASX:VTI)?

In this article, I'm going to take a look at Visioneering Technologies Inc’s (ASX:VTI) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … This is a positive sign for potential investors as these firms play an important role in aligning company policy with shareholder returns. … Private Company Ownership Another important group of owners for potential investors in VTI are private companies that hold a stake of 5.01% in VTI.

Simply Wall St -

Was Visioneering Technologies Inc's (ASX:VTI) Earnings Decline Part Of A Broader Industry Downturn?

For Visioneering Technologies, its most recent earnings (trailing twelve month) is -US$16.98M, which, relative to the previous year's level, has become more negative. … This suggests that any recent headwind the industry is enduring, it’s hitting Visioneering Technologies harder than its peers.What does this mean? … I suggest you continue to research Visioneering Technologies to get a better picture of the stock by looking at: Financial Health: Is VTI’s operations financially sustainable?

Simply Wall St -

Is Visioneering Technologies Inc (ASX:VTI) A Healthcare Industry Laggard Or Leader?

Given the lack of analyst consensus in Visioneering Technologies’s outlook, we could potentially assume the stock’s growth rate broadly follows its healthcare equipment industry peers. … If you’ve been keeping an eye on the healthcare equipment sector, you may have just missed the boat on high growth potential as the market seems to have well and truly priced it into these stocks. … The sector is relatively more expensive than the rest of the market which makes it less attractive to enter into companies like Visioneering Technologies right now.

Simply Wall St -

When Will Visioneering Technologies Inc (ASX:VTI) Come Back To Market?

How fast Visioneering Technologies runs down its cash supply over time is known as the cash burn rate. … ASX:VTI Income Statement Dec 20th 17 When will Visioneering Technologies need to raise more cash? … My cash burn analysis suggests that Visioneering Technologies has a cash runway of 2.3 years, given its current level of cash holdings.

Simply Wall St -

VTI Company Info

Description

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of its NaturalVue daily disposable multi-focal contact lenses for adults with presbyopia and children with myopia in the United States. The company was founded in 2008 and is headquartered in Alpharetta, Georgia.

Details
Name: Visioneering Technologies, Inc.
VTI
Exchange: ASX
Founded: 2008
A$18,397,827
248,619,294
Website: http://www.vtivision.com
Address: Visioneering Technologies, Inc.
10745 Westside Way,
Suite 200,
Alpharetta,
Georgia, 30009,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX VTI CDI 1:1 Australian Securities Exchange AU AUD 28. Mar 2017
ASX VTI Class A Common Stock Australian Securities Exchange AU AUD 23. Apr 2019
Number of employees
Current staff
Staff numbers
45
Visioneering Technologies employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/23 10:36
End of day share price update: 2019/04/23 00:00
Last estimates confirmation: 2019/04/09
Last earnings filing: 2019/02/18
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.